Moderna vaccine found highly effective at preventing covid. According to Bloomberg Quint on Mon Nov 16, “Moderna shares rose more than 9% in pre-market U.S.”
Shares of Moderna are up by 2.88% to $91.45 at 09:44 EST on Thursday. The Nasdaq Stock Market is falling 0.82% to $11801.6, on what seems, as yet, an all-around negative exchanging session on The Nasdaq Stock Market.
Moderna’s last close was $93.15, below its 52-week high of $103.2.
Moderna’s sales growth is 1074.4% for the present quarter and 2299% for the next. The company’s growth estimates for the ongoing quarter and the next are -73% and 142.9%, respectively.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s stock is valued at $91.45 at 09:44 EST, way below its 52-week high of $103.2 and way above its 52-week low of $17.68.
Moderna’s worth is way above its 50 day moving average of $74.25 and way higher than its 200 day moving average of $68.61.